Magnotto

CKD OTTO Pharma is a joint venture pharmaceutical company established between South Korea's Chong Kun Dang Pharm and Indonesia's Otto Pharmaceutical Industries, a subsidiary of the Mensa Group. The company specializes in the manufacturing and distribution of oncology medications, operating a state-of-the-art production facility in Indonesia that adheres to international Good Manufacturing Practice (GMP) standards. It is notable for being the first oncology manufacturer in Indonesia to receive Halal certification for its products. CKD OTTO Pharma focuses on providing high-quality, affordable cancer treatments to patients across the ASEAN, Middle East, and North Africa (MENA) regions.